CPD-1224 is an orally effective ALK inhibitor, a derivative of an ALK inhibitor that connects to the cereblon ligand. CPD-1224 targets the EML4-ALK oncogenic fusion protein and degrades both ALK and the mutant forms L1196M/G1202R. CPD-1224 can slow down tumor growth[1].
Molekulargewicht:
855.40
Reinheit:
99.83
CAS Nummer:
[2891620-68-9]
Formel:
C43H47ClN8O7S
Target-Kategorie:
Anaplastic lymphoma kinase (ALK)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
